Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.26%17.12M | 13.32%17.61M | 10.18%14.47M | 28.19%61.32M | 28.56%16.38M | 46.94%16.27M | 29.78%15.54M | 8.97%13.13M | -8.66%47.84M | 32.37%12.74M |
| Cost of revenue | -8.16%10.14M | -2.01%10.87M | -2.05%9.38M | 17.09%44.85M | 24.02%12.55M | 27.26%11.04M | 15.08%11.09M | -2.95%9.58M | -11.04%38.31M | 21.76%10.12M |
| Gross profit | 33.59%6.98M | 51.55%6.74M | 43.16%5.09M | 72.81%16.47M | 46.06%3.83M | 118.20%5.23M | 90.49%4.45M | 62.94%3.55M | 2.32%9.53M | 99.31%2.63M |
| Operating expense | -0.14%3.59M | 9.60%3.55M | -12.65%2.82M | -31.46%9.71M | 32.03%4.39M | -13.16%3.59M | -6.42%3.24M | -2.74%3.23M | 5.44%14.17M | 23.54%3.33M |
| Selling and administrative expenses | -0.14%3.59M | 9.60%3.55M | -12.65%2.82M | -3.30%13.95M | 32.03%4.39M | -13.16%3.59M | -6.42%3.24M | -2.74%3.23M | 7.35%14.43M | 23.54%3.33M |
| -Selling and marketing expense | 9.62%262K | 10.14%239K | 8.92%232K | 10.92%912.22K | 8.50%217K | 26.46%239K | -1.36%217K | 0.00%213K | 11.86%822.38K | 9.17%200K |
| -General and administrative expense | -0.84%3.32M | 9.57%3.31M | -14.18%2.59M | -4.16%13.04M | 33.54%4.17M | -15.05%3.35M | -6.76%3.02M | -2.93%3.01M | 7.09%13.61M | 24.59%3.13M |
| Other operating expenses | ---- | ---- | ---- | 5.10%268.01K | ---- | ---- | ---- | ---- | --255.01K | ---- |
| Total other operating income | ---- | ---- | ---- | 780.36%4.51M | ---- | ---- | ---- | ---- | --512.06K | ---- |
| Operating profit | 107.57%3.4M | 163.80%3.19M | 593.58%2.27M | 245.36%6.75M | 20.57%-556K | 194.13%1.64M | 207.56%1.21M | 128.79%327K | -12.45%-4.64M | 49.07%-700K |
| Net non-operating interest income (expenses) | -99.19%-245K | -30.65%-162K | 12.12%-116K | 20.36%-456.62K | -1.28%-79K | 45.81%-123K | 18.42%-124K | -2.33%-132K | -3.38%-573.39K | 41.18%-78K |
| Non-operating interest income | ---- | ---- | ---- | -86.13%1.8K | ---- | ---- | ---- | ---- | -7.55%12.94K | ---- |
| Non-operating interest expense | 99.19%245K | 30.65%162K | -12.12%116K | -21.82%458.42K | 1.28%79K | -45.81%123K | -18.42%124K | 2.33%132K | 3.12%586.33K | -46.80%78K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 201.46%113.45K | -990.61%-111.82K | ||||||||
| Less:Write off | ---- | ---- | ---- | -201.46%-113.45K | ---- | ---- | ---- | ---- | 990.61%111.82K | ---- |
| Other non-operating income (expenses) | 80.09%-92K | 85.58%-15K | 448.75%878K | 9,661.36%4.21M | 1,685.22%4.61M | -340.00%-462K | -167.53%-104K | -19.19%160K | -102.78%-44K | -115.14%-291K |
| Income before tax | 190.97%3.06M | 207.03%3.02M | 753.52%3.03M | 220.23%6.41M | 472.12%3.98M | 150.80%1.05M | 187.44%982K | 133.27%355K | -72.40%-5.33M | -350.07%-1.07M |
| Income tax | 0 | 147K | 1K | 155.28%247.56K | 155.36%248K | 0 | 0 | 0 | -349.96%-447.84K | -350.05%-448K |
| Net income | 190.97%3.06M | 192.06%2.87M | 753.24%3.03M | 226.19%6.16M | 700.64%3.73M | 150.80%1.05M | 187.44%982K | 133.27%355K | -49.27%-4.88M | -350.09%-621K |
| Net income continuous operations | 190.97%3.06M | 192.06%2.87M | 753.24%3.03M | 226.19%6.16M | 700.64%3.73M | 150.80%1.05M | 187.44%982K | 133.27%355K | -49.27%-4.88M | -350.09%-621K |
| Noncontrolling interests | 122.62%19K | 470.00%37K | -120.17%-24K | 89.93%-78.79K | 45.55%-104K | 49.70%-84K | 95.74%-10K | 162.63%119K | -173.41%-782.72K | 42.86%-191K |
| Net income attributable to the company | 167.78%3.04M | 185.38%2.83M | 1,193.64%3.05M | 252.21%6.24M | 991.63%3.83M | 159.66%1.14M | 211.71%992K | 126.91%236K | -37.36%-4.1M | -173.81%-430K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 167.78%3.04M | 185.38%2.83M | 1,193.64%3.05M | 252.21%6.24M | 991.63%3.83M | 159.66%1.14M | 211.71%992K | 126.91%236K | -37.36%-4.1M | -173.81%-430K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 113.79%0.0124 | 130.00%0.0115 | 933.33%0.0124 | 251.92%0.0316 | 981.82%0.0194 | 159.79%0.0058 | 211.11%0.005 | 127.27%0.0012 | -37.75%-0.0208 | -173.33%-0.0022 |
| Diluted earnings per share | 113.79%0.0124 | 130.00%0.0115 | 933.33%0.0124 | 251.92%0.0316 | 981.82%0.0194 | 159.79%0.0058 | 211.11%0.005 | 127.27%0.0012 | -37.75%-0.0208 | -174.48%-0.0022 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.